Wei Zhu
- Cancer Research top 0.2%
- MicroRNA in disease regulation 70
- Cancer-related molecular mechanisms research 52
- Molecular Biology top 1%
- Circular RNAs in diseases 38
- RNA modifications and cancer 30
- Extracellular vesicles in disease 23
- Bone Metabolism and Diseases 10
- Oncology top 2%
- Immunology top 5%
-
- Kidney Stones and Urolithiasis Treatments 13
-
- Bone health and osteoporosis research 9
- Co-authors
- Tongshan WangXin ZhouZebo HuangPing LiuYongqian ShuDanxia ZhuHuo ZhangWen‐Fang Cheng
- Journals
- Circulation (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wei Zhu
173 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Cancer Research 3.8k
- Molecular Biology 4.7k
- Oncology 1.1k
- Immunology 485
- Pulmonary and Respiratory Medicine 716
Countries citing papers authored by Wei Zhu
This map shows the geographic impact of Wei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zhu more than expected).
Fields of papers citing papers by Wei Zhu
This network shows the impact of papers produced by Wei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zhu. The network helps show where Wei Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 16 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 6 | |
| 11 | 2019 | 4 | |
| 12 | 2019 | 41 | |
| 13 | 2019 | 16 | |
| 14 | 2016 | 114 | |
| 15 | 2016 | 84 | |
| 16 | 2016 | 57 | |
| 17 | 2016 | 186 | |
| 18 | 2014 | 57 | |
| 19 | 2011 | 173 | |
| 20 | 2010 | 251 |
About Wei Zhu
Wei Zhu is a scholar working on Cancer Research, Molecular Biology and Nephrology, having authored 179 papers that have together received 6.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (70 papers), Cancer-related molecular mechanisms research (52 papers), Circular RNAs in diseases (38 papers), RNA modifications and cancer (30 papers), Extracellular vesicles in disease (23 papers), Kidney Stones and Urolithiasis Treatments (13 papers), Bone Metabolism and Diseases (10 papers) and Bone health and osteoporosis research (9 papers). The work is most often cited by research in Cancer Research (3.8k citations), Molecular Biology (4.7k citations) and Oncology (1.1k citations). Wei Zhu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Tongshan Wang, Xin Zhou, Zebo Huang, Ping Liu, Yongqian Shu, Danxia Zhu, Huo Zhang, Wen‐Fang Cheng, Lian‐Wen Qi and Yongqian Shu. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.